封面
市场调查报告书
商品编码
1609645

2024-2032 年日本神经刺激设备市场报告(按刺激类型、设备类型、应用、最终用户和地区)

Japan Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End User, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2023年日本神经刺激设备市场规模达7.785IMARC Group美元。神经系统疾病盛行率上升、人口快速老化、快速的技术进步、严格的监管标准、激增的合作研究工作、对非药物疗法的接受程度不断提高、有利的报销政策和策略性产业合作伙伴关係是推动市场成长的一些关键因素。

神经刺激设备是复杂的医疗仪器,旨在透过受控的电脉衝精确调节神经系统。它们被策略性地放置在特定的神经通路或大脑区域附近,以施加精确的刺激,有效地影响神经活动。它们的应用涵盖不同的医学领域,包括疼痛管理、神经系统疾病和心理健康状况。在疼痛管理领域,神经刺激装置已证明可以透过中断疼痛讯号来缓解慢性疼痛。对于帕金森氏症等神经系统疾病,它们提供了一种调节异常大脑活动的方法。此外,它们还透过针对情绪调节迴路来帮助治疗忧郁症等情绪障碍。神经刺激装置的主要优点在于其非侵入性,为外科手术提供了更安全的替代方案。这可以最大限度地减少相关的手术风险并加速康復。此外,患者可以更好地控制他们的治疗,从而调整刺激参数,增强他们的整体体验,并有助于改善结果。这些设备有多种类型,每种类型都针对特定的医疗条件量身定制,例如脊髓和深部脑部刺激器。

日本神经刺激设备市场趋势:

日本神经刺激设备市场受到几个关键驱动因素的影响,例如帕金森氏症和癫痫等神经系统疾病盛行率的上升。此外,日本不断增长的老年人口凸显了对创新治疗解决方案的需求,从而进一步扩大了市场成长。此外,医疗保健专业人员和患者对神经刺激疗法益处的认识不断提高,正在促进市场扩张。与此一致,神经刺激设备的技术进步,特别是在精确性和微创技术方面的进步,引起了医生的关注,促进了市场的成长。此外,该国医疗器材製造商和研究机构之间的合作也促进了尖端神经刺激技术的发展,从而刺激了市场成长。此外,为了减轻与药物相关的副作用,越来越倾向于非药物疗法,推动了对神经刺激设备的需求,进一步促进了市场成长。除此之外,这些设备在治疗慢性疼痛和情绪障碍方面的接受度越来越高,以及有利的报销政策和强大的医疗基础设施的存在,正在推动全国范围内的市场扩张。

日本神经刺激设备市场细分:

刺激类型见解:

  • 内部刺激
  • 外部刺激

设备类型见解:

  • SCS(脊髓刺激)设备
  • DBS(深部脑部刺激)设备
  • SNS(荐神经刺激)设备
  • VNS(迷走神经刺激)设备
  • GES(胃电刺激)设备
  • 经皮神经电刺激装置
  • 经颅磁刺激装置
  • 其他的

应用见解:

  • 疼痛管理
  • 癫痫
  • 特发性震颤
  • 尿失禁和大便失禁
  • 沮丧
  • 肌张力失调
  • 帕金森氏症
  • 其他的

最终使用者见解:

  • 復健中心
  • 医院
  • 医疗诊所
  • 其他的

竞争格局:

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外,也提供了所有主要公司的详细资料。

本报告回答的关键问题:

  • 到目前为止,日本神经刺激设备市场的表现如何,未来几年又会如何表现?
  • COVID-19 对日本神经刺激设备市场有何影响?
  • 日本神经刺激设备市场依刺激类型划分是怎样的?
  • 日本神经刺激设备市场依设备类型划分是怎样的?
  • 日本神经刺激设备市场依应用划分是怎样的?
  • 日本神经刺激设备市场以最终用户划分是怎样的?
  • 日本神经刺激设备市场价值链的各个阶段是什么?
  • 日本神经刺激设备的关键驱动因素和挑战是什么?
  • 日本神经刺激设备市场的结构如何?
  • 日本神经刺激设备市场的竞争程度如何?

本报告回答的关键问题:

  • 到目前为止,日本神经刺激设备市场的表现如何,未来几年又会如何表现?
  • COVID-19 对日本神经刺激设备市场有何影响?
  • 日本神经刺激设备市场依刺激类型划分是怎样的?
  • 日本神经刺激设备市场依设备类型划分是怎样的?
  • 日本神经刺激设备市场依应用划分是怎样的?
  • 日本神经刺激设备市场以最终用户划分是怎样的?
  • 日本神经刺激设备市场价值链的各个阶段是什么?
  • 日本神经刺激设备的关键驱动因素和挑战是什么?
  • 日本神经刺激设备市场的结构如何?
  • 日本神经刺激设备市场的竞争程度如何?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:日本神经刺激设备市场 - 简介

  • 概述
  • 市场动态
  • 产业动态
  • 竞争情报

第 5 章:日本神经刺激设备市场格局

  • 历史与当前市场趋势(2018-2023)
  • 市场预测(2024-2032)

第 6 章:日本神经刺激设备市场 - 细分:按刺激类型

  • 内部刺激
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 外部刺激
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)

第 7 章:日本神经刺激设备市场 - 细分:按设备类型

  • SCS(脊髓刺激)设备
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • DBS(深部脑部刺激)设备
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • SNS(荐神经刺激)设备
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • VNS(迷走神经刺激)设备
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • GES(胃电刺激)设备
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 经皮神经电刺激装置
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 经颅磁刺激装置
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 其他的
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)

第 8 章:日本神经刺激设备市场 - 细分:按应用分类

  • 疼痛管理
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 癫痫
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 特发性震颤
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 尿失禁和大便失禁
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 沮丧
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 肌张力失调
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 帕金森氏症
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 其他的
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)

第 9 章:日本神经刺激设备市场 - 细分:依最终用户划分

  • 復健中心
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 医院
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 医疗诊所
    • 概述
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)
  • 其他的
    • 历史与当前市场趋势(2018-2023)
    • 市场预测(2024-2032)

第 10 章:日本神经刺激设备市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争仪表板
  • 公司评估象限

第 11 章:关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 12 章:日本神经刺激设备市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 司机
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 13 章:附录

简介目录
Product Code: SR112024A21886

Japan neurostimulation devices market size reached US$ 778.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,472.3 Million by 2032, exhibiting a growth rate (CAGR) of 12.30% during 2024-2032. Rising prevalence of neurological disorders, burgeoning aging population, rapid technological advancements, stringent regulatory standards, surging collaborative research efforts, increasing acceptance of non-pharmacological therapies, favorable reimbursement policies, and strategic industry partnership represent some of the key factors driving the market growth.

Neurostimulation devices are sophisticated medical instruments designed for the precise modulation of the nervous system through controlled electrical impulses. They are strategically placed near specific nerve pathways or brain regions to exert precise stimulation, effectively influencing neural activity. Their applications span diverse medical fields, including pain management, neurological disorders, and mental health conditions. In the realm of pain management, neurostimulation devices have demonstrated effectiveness in alleviating chronic pain by interrupting pain signals. For neurological disorders, such as Parkinson's disease, they offer a means to regulate abnormal brain activity. Additionally, they help in treating mood disorders like depression by targeting mood-regulating circuits. A primary advantage of neurostimulation devices lies in their non-invasive nature, offering a safer alternative to surgical procedures. This minimizes the associated surgical risks and accelerates recovery. Moreover, patients can exercise greater control over their treatment, allowing for adjustments in stimulation parameters, enhancing their overall experience, and contributing to improved outcomes. These devices are available in various types, each tailored to specific medical conditions, such as spinal cord and deep brain stimulators.

Japan Neurostimulation Devices Market Trends:

The Japan neurostimulation devices market is influenced by several key drivers, such as the rising prevalence of neurological disorders, including Parkinson's disease and epilepsy. Additionally, the burgeoning geriatric population in Japan underscores the need for innovative therapeutic solutions, further amplifying market growth. Furthermore, increasing awareness about the benefits of neurostimulation therapies among both healthcare professionals and patients is facilitating the market expansion. In line with this, technological advancements in neurostimulation devices, particularly in terms of precision and minimally invasive techniques, have attracted the attention of medical practitioners, fostering the market growth. Moreover, the collaborative efforts between medical device manufacturers and research institutions in the country have also resulted in the development of cutting-edge neurostimulation technologies, which is stimulating the market growth. Furthermore, the growing inclination towards non-pharmacological therapies, to mitigate the side effects associated with medications, has driven the demand for neurostimulation devices, further boosting the market growth. Apart from this, the increasing acceptance of these devices in the management of chronic pain and mood disorders and the presence of favorable reimbursement policies and robust healthcare infrastructure are fueling market expansion across the country.

Japan Neurostimulation Devices Market Segmentation:

Stimulation Type Insights:

  • Internal Stimulation
  • External Stimulation

Device Type Insights:

  • SCS (Spinal Cord Stimulation) Devices
  • DBS (Deep Brain Stimulation) Devices
  • SNS (Sacral Nerve Stimulation) Devices
  • VNS (Vagus Nerve Stimulation) Devices
  • GES (Gastric Electrical Stimulation) Devices
  • Transcutaneous Electrical Nerve Stimulation Devices
  • Transcranial Magnetic Stimulation Devices
  • Others

Application Insights:

  • Pain Management
  • Epilepsy
  • Essential Tremors
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Parkinson's Disease
  • Others

End User Insights:

  • Rehabilitation Centers
  • Hospitals
  • Medical Clinics
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan neurostimulation devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan neurostimulation devices market?
  • What is the breakup of the Japan neurostimulation devices market on the basis of stimulation type?
  • What is the breakup of the Japan neurostimulation devices market on the basis of device type?
  • What is the breakup of the Japan neurostimulation devices market on the basis of application?
  • What is the breakup of the Japan neurostimulation devices market on the basis of end user?
  • What are the various stages in the value chain of the Japan neurostimulation devices market?
  • What are the key driving factors and challenges in the Japan neurostimulation devices?
  • What is the structure of the Japan neurostimulation devices market and who are the key players?
  • What is the degree of competition in the Japan neurostimulation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Neurostimulation Devices Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Neurostimulation Devices Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Neurostimulation Devices Market - Breakup by Stimulation Type

  • 6.1 Internal Stimulation
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 External Stimulation
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)

7 Japan Neurostimulation Devices Market - Breakup by Device Type

  • 7.1 SCS (Spinal Cord Stimulation) Devices
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 DBS (Deep Brain Stimulation) Devices
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 SNS (Sacral Nerve Stimulation) Devices
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 VNS (Vagus Nerve Stimulation) Devices
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 GES (Gastric Electrical Stimulation) Devices
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2018-2023)
    • 7.5.3 Market Forecast (2024-2032)
  • 7.6 Transcutaneous Electrical Nerve Stimulation Devices
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2018-2023)
    • 7.6.3 Market Forecast (2024-2032)
  • 7.7 Transcranial Magnetic Stimulation Devices
    • 7.7.1 Overview
    • 7.7.2 Historical and Current Market Trends (2018-2023)
    • 7.7.3 Market Forecast (2024-2032)
  • 7.8 Others
    • 7.8.1 Historical and Current Market Trends (2018-2023)
    • 7.8.2 Market Forecast (2024-2032)

8 Japan Neurostimulation Devices Market - Breakup by Application

  • 8.1 Pain Management
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Epilepsy
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Essential Tremors
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)
  • 8.4 Urinary and Fecal Incontinence
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2018-2023)
    • 8.4.3 Market Forecast (2024-2032)
  • 8.5 Depression
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2018-2023)
    • 8.5.3 Market Forecast (2024-2032)
  • 8.6 Dystonia
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2018-2023)
    • 8.6.3 Market Forecast (2024-2032)
  • 8.7 Parkinson's Disease
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2018-2023)
    • 8.7.3 Market Forecast (2024-2032)
  • 8.8 Others
    • 8.8.1 Historical and Current Market Trends (2018-2023)
    • 8.8.2 Market Forecast (2024-2032)

9 Japan Neurostimulation Devices Market - Breakup by End User

  • 9.1 Rehabilitation Centers
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2018-2023)
    • 9.1.3 Market Forecast (2024-2032)
  • 9.2 Hospitals
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2018-2023)
    • 9.2.3 Market Forecast (2024-2032)
  • 9.3 Medical Clinics
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2018-2023)
    • 9.3.3 Market Forecast (2024-2032)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2018-2023)
    • 9.4.2 Market Forecast (2024-2032)

10 Japan Neurostimulation Devices Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Neurostimulation Devices Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix